Altered ATRX/DAXX Expression and Telomere Length of Pancreatic Neuroendocrine Tumors in MEN-1 Syndrome

被引：0
|
作者：
de Wilde, R. F.
Heaphy, C. M.
Maitra, A.
Meeker, A. K.
Edil, B. H.
Wolfgang, C. L.
Ellison, T.
Schulick, R. D.
Molenaar, I. Q.
Valk, G. D.
Vriens, M. R.
Rinkes, I. H. M. Borel
Offerhaus, G. J. A.
Hruban, R. H.
Matsukuma, K. E.
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1843
引用
收藏
页码：442A / 442A
页数：1
相关论文
共 50 条
  • [21] DAXX/ATRX and MEN1 genes are stong prognostic markers in pancreatic neuroendocrine tumor.
    Park, Joo Kyung
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    Lee, Se-Hoon
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [22] Clinical Relevance of ATRX/DAXX Gene Mutations and ALT in Functioning Pancreatic Neuroendocrine Tumors
    van 't Veld, Brenna R.
    Hackeng, Wenzel M.
    Luchini, Claudio
    Brosens, Lodewijk A. A.
    Dreijerink, Koen M. A.
    ENDOCRINE PATHOLOGY, 2025, 36 (01)
  • [23] Immunohistochemical Detection of Loss Expression of ATRX/DAXX in Neuroendocrine Tumors from Various Organs
    Piazza, Yelena
    Liu, Haiyan
    Lin, Fan
    LABORATORY INVESTIGATION, 2017, 97 : 450A - 450A
  • [24] Octreotide Use in a Patient with MEN-1 Syndrome and Multifocal Pancreatic Neuroendocrine Tumors: A Case Report and Review of the Literature
    Kemm, Matthew H.
    Manly, Cory D.
    Hoang, Thanh D.
    Mai, Vinh Q.
    Shakir, Mohamed K. M.
    CASE REPORTS IN GASTROINTESTINAL MEDICINE, 2019, 2019
  • [25] Differences in the Mutation of DAXX, ATRX, and MENIN in Pancreatic Neuroendocrine Tumors From Black and White Patients
    Herring, Brendon R.
    Guenter, Rachael E.
    Chen, Herbert
    Dhall, Deepti
    Rose, J. Bart
    PANCREAS, 2022, 51 (03) : E51 - E51
  • [26] Immunohistochemical Detection of Loss Expression of ATRX/DAXX in Neuroendocrine Tumors from Various Organs
    Piazza, Yelena
    Liu, Haiyan
    Lin, Fan
    MODERN PATHOLOGY, 2017, 30 : 450A - 450A
  • [27] Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
    Marinoni, Ilaria
    Kurrer, Anja Schmitt
    Vassella, Erik
    Dettmer, Matthias
    Rudolph, Thomas
    Banz, Vanessa
    Hunger, Fabio
    Pasquinelli, Silvan
    Speel, Ernst-Jan
    Perren, Aurel
    GASTROENTEROLOGY, 2014, 146 (02) : 453 - +
  • [28] Loss of ATRX and DAXX in pancreatic neuroendocrine tumors: Association with recurrence risk, cellular phenotype, and heterogeneity
    Yasunaga, Yoichi
    Tanaka, Mariko
    Arita, Junichi
    Hasegawa, Kiyoshi
    Ushiku, Tetsuo
    HUMAN PATHOLOGY, 2024, 150 : 51 - 57
  • [29] Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
    Singhi, Aatur D.
    Liu, Ta-Chiang
    Roncaioli, Justin L.
    Cao, Dengfeng
    Zeh, Herbert J.
    Zureikat, Amer H.
    Tsung, Allan
    Marsh, J. Wallis
    Lee, Kenneth K.
    Hogg, Melissa E.
    Bahary, Nathan
    Brand, Randall E.
    McGrath, Kevin M.
    Slivka, Adam
    Cressman, Kristi L.
    Fuhrer, Kimberly
    O'Sullivan, Roderick J.
    CLINICAL CANCER RESEARCH, 2017, 23 (02) : 600 - 609
  • [30] Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients With Pancreatic Neuroendocrine Tumors
    Singhi, A. D.
    Liu, T. -C.
    Roncaioli, J. L.
    Zeh, H. J.
    Zureikat, A. H.
    Tsung, A.
    Marsh, J. W.
    Lee, K. K.
    Hogg, M. E.
    Bahary, N.
    Brand, R. E.
    McGrath, K.
    Slivka, A.
    Cressman, K. L.
    Fuhrer, K.
    O'Sullivan, R. J.
    PANCREAS, 2016, 45 (10) : 1539 - 1539
12345